Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 3/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CNR2 | P34972 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4984316 | 0.99 | HTR2A (0.38) | HTR2ACYP2C9 | |
| SCHEMBL4981814 | 0.78 | GRIN2D (0.40) | CNR2 | |
| SCHEMBL6547448 | 0.72 | RELA (0.48) | HTR2ACYP2C9 | |
| SCHEMBL14570387 | 0.71 | RELA (0.46) | CYP2C9CNR2 | |
| SCHEMBL13475128 | 0.71 | RELA (0.46) | CYP2C9CNR2 | |
| SCHEMBL4979723 | 0.70 | CYP2C9 (0.41) | CYP2C9 | |
| SCHEMBL5448297 | 0.69 | ALOX5 (0.51) | — | |
| SCHEMBL4983301 | 0.69 | MME (0.41) | — | |
| SCHEMBL12292333 | 0.67 | CYP2C9 (0.49) | CYP2C9 | |
| SCHEMBL14570389 | 0.67 | TRPM8 (0.45) | CYP2C9CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004072255-A2 | METHODS OF TREATING DISEASE | SCION PHARMACEUTICALS, INC. (US) | 2004-08-26 | — | — | WO | disclosed |
| EP-0751767-A4 | THERAPEUTIC GUANIDINES | CAMBRIDGE NEUROSCIENCE INC (US) | 1997-12-10 | — | — | EP | disclosed |
| EP-0751767-A1 | THERAPEUTIC GUANIDINES | CAMBRIDGE NEUROSCIENCE, INC. (US) | 1997-01-08 | — | — | EP | disclosed |
| WO-1995020950-A1 | THERAPEUTIC GUANIDINES | CAMBRIDGE NEUROSCIENCE, INC. (US) | 1995-08-10 | — | — | WO | disclosed |